ZA201908087B - Treatment for migraine - Google Patents
Treatment for migraineInfo
- Publication number
- ZA201908087B ZA201908087B ZA2019/08087A ZA201908087A ZA201908087B ZA 201908087 B ZA201908087 B ZA 201908087B ZA 2019/08087 A ZA2019/08087 A ZA 2019/08087A ZA 201908087 A ZA201908087 A ZA 201908087A ZA 201908087 B ZA201908087 B ZA 201908087B
- Authority
- ZA
- South Africa
- Prior art keywords
- migraine
- leucine
- treatment
- acetyl
- treating
- Prior art date
Links
- 208000019695 Migraine disease Diseases 0.000 title abstract 3
- 206010027599 migraine Diseases 0.000 title abstract 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 2
- WXNXCEHXYPACJF-ZETCQYMHSA-N N-acetyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(C)=O WXNXCEHXYPACJF-ZETCQYMHSA-N 0.000 abstract 2
- 229960000669 acetylleucine Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1709459.0A GB201709459D0 (en) | 2017-06-14 | 2017-06-14 | Treatment for migraine |
| PCT/IB2018/054676 WO2018229738A1 (en) | 2017-06-14 | 2018-06-25 | Treatment for migraine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201908087B true ZA201908087B (en) | 2024-11-27 |
Family
ID=59358204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2019/08087A ZA201908087B (en) | 2017-06-14 | 2019-12-05 | Treatment for migraine |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US11471434B2 (enExample) |
| EP (1) | EP3638370B1 (enExample) |
| JP (1) | JP7130739B2 (enExample) |
| KR (1) | KR102594130B1 (enExample) |
| CN (1) | CN111093772B (enExample) |
| AU (1) | AU2018284330B2 (enExample) |
| CY (1) | CY1123860T1 (enExample) |
| DK (1) | DK3638370T3 (enExample) |
| ES (1) | ES2847169T3 (enExample) |
| GB (1) | GB201709459D0 (enExample) |
| HR (1) | HRP20210108T1 (enExample) |
| HU (1) | HUE053089T2 (enExample) |
| IL (1) | IL271211B2 (enExample) |
| LT (1) | LT3638370T (enExample) |
| MA (1) | MA49396B1 (enExample) |
| MD (1) | MD3638370T2 (enExample) |
| MX (1) | MX387909B (enExample) |
| PL (1) | PL3638370T3 (enExample) |
| PT (1) | PT3638370T (enExample) |
| RS (1) | RS61481B1 (enExample) |
| SG (1) | SG11201912146RA (enExample) |
| SI (1) | SI3638370T1 (enExample) |
| SM (1) | SMT202100037T1 (enExample) |
| WO (1) | WO2018229738A1 (enExample) |
| ZA (1) | ZA201908087B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019221886B2 (en) * | 2018-02-15 | 2024-08-08 | Intrabio Ltd | Therapeutic agents for treating restless legs syndrome |
| JP7471298B2 (ja) | 2018-12-06 | 2024-04-19 | イントラビオ エルティーディー | アセチル－ロイシンの重水素化類似体 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8701662L (sv) * | 1987-04-22 | 1988-10-23 | Gelder Nico M Van | Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna |
| US20040127501A1 (en) * | 2002-09-24 | 2004-07-01 | Zhengming Chen | Therapeutic agents useful for treating pain |
| US20060063827A1 (en) | 2004-09-23 | 2006-03-23 | Yu Ruey J | Systemic administration of therapeutic amino acids and N-acetylamino acids |
| MY142655A (en) * | 2003-06-12 | 2010-12-15 | Euro Celtique Sa | Therapeutic agents useful for treating pain |
| EP1641775B1 (en) * | 2003-07-03 | 2009-02-18 | Euro-Celtique S.A. | 2-pyridine alkyne derivatives useful for treating pain |
| CN1856484B (zh) * | 2003-07-24 | 2010-09-22 | 欧洲凯尔蒂克公司 | 用于治疗或预防疼痛的杂芳基-四氢吡啶基化合物 |
| JP4634385B2 (ja) * | 2003-09-22 | 2011-02-16 | ユーロ−セルティーク エス．エイ． | 疼痛の治療に有用なフェニル−カルボキサミド化合物 |
| DE602004017481D1 (de) * | 2003-09-22 | 2008-12-11 | Euro Celtique Sa | Zur behandlung von schmerzen geeignete therapeutische mittel |
| DE602004019576D1 (de) * | 2003-12-30 | 2009-04-02 | Euro Celtique Sa | Zur behandlung von schmerzen geeignete piperazine |
| FR2905600B1 (fr) | 2006-09-13 | 2010-01-15 | Pf Medicament | Traitement des vertiges par l'acetyl-l-leucine. |
| TN2010000251A1 (fr) | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| JP5876423B2 (ja) * | 2010-06-22 | 2016-03-02 | 塩野義製薬株式会社 | Ｔｒｐｖ１阻害活性を有する化合物とその使用 |
| EP3103469B1 (en) | 2010-06-25 | 2020-12-09 | Shire Human Genetic Therapies, Inc. | Cns delivery of therapeutic agents |
| ES2732818T3 (es) * | 2010-11-09 | 2019-11-26 | Mannkind Corp | Composición que comprende un agonista de receptores de serotonina y una dicetopiperazina para tratar migrañas |
| WO2013021276A1 (en) * | 2011-08-10 | 2013-02-14 | Purdue Pharma L.P. | Trpv1 antagonists including dihydroxy substituent and uses thereof |
| KR102791288B1 (ko) | 2016-04-19 | 2025-04-03 | 인트라바이오 리미티드 | 이동성 및 인지 기능을 개선시키기 위한 아세틸-류신 또는 이의 약제학적으로 허용되는 염 |
| MA43876B1 (fr) | 2016-08-11 | 2019-04-30 | Intrabio Ltd | Compositions pharmaceutiques et leur utilisations contre les maladies de surcharge lysosomale |
| AU2017308865B2 (en) | 2016-08-11 | 2023-04-13 | Intrabio Limited | Therapeutic agents for neurodegenerative diseases |
| LT3600276T (lt) | 2017-03-28 | 2023-08-10 | Intrabio Ltd | Betahistinas arba farmaciniu požiūriu priimtina jo druska ir monoaminooksidazės inhibitorius, skirti panaudoti subjekto gydymui arba profilaktikai vieno arba daugiau vestibulinio galvos svaigimo simptomų |
| RU2763425C2 (ru) | 2017-10-18 | 2021-12-29 | Интрабио Лимитед | Терапевтические агенты для нейродегенеративных заболеваний |
| WO2019079536A1 (en) | 2017-10-18 | 2019-04-25 | Intrabio Ltd | THERAPEUTIC AGENTS FOR IMPROVED MOBILITY AND COGNITIVE FUNCTION AND FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND LYSOSOMAL STORAGE DISORDERS |
| AU2019221886B2 (en) | 2018-02-15 | 2024-08-08 | Intrabio Ltd | Therapeutic agents for treating restless legs syndrome |
| JP7471298B2 (ja) | 2018-12-06 | 2024-04-19 | イントラビオ エルティーディー | アセチル－ロイシンの重水素化類似体 |
| SI3934637T1 (sl) | 2019-03-02 | 2024-10-30 | Intrabio Ltd Summit House | (N-)acetil-L-levcin za uporabo pri zdravljenju travmatske poškodbe možganov |
| PL3989962T3 (pl) | 2019-06-28 | 2025-11-17 | Intrabio Ltd | Terapia skojarzona acetyloleucyną i miglustatem w leczeniu lizosomalnej choroby spichrzeniowej |
| US20230051742A1 (en) | 2020-01-13 | 2023-02-16 | Intrabio Ltd. | Treatment of late-onset neurodegenerative diseases in heterozygous npc1 gene mutation carriers |
-
2017
- 2017-06-14 GB GBGB1709459.0A patent/GB201709459D0/en not_active Ceased
-
2018
- 2018-06-25 PL PL18749124T patent/PL3638370T3/pl unknown
- 2018-06-25 HU HUE18749124A patent/HUE053089T2/hu unknown
- 2018-06-25 MX MX2019014784A patent/MX387909B/es unknown
- 2018-06-25 CN CN201880039532.2A patent/CN111093772B/zh active Active
- 2018-06-25 JP JP2020519196A patent/JP7130739B2/ja active Active
- 2018-06-25 MA MA49396A patent/MA49396B1/fr unknown
- 2018-06-25 IL IL271211A patent/IL271211B2/en unknown
- 2018-06-25 EP EP18749124.6A patent/EP3638370B1/en active Active
- 2018-06-25 HR HRP20210108TT patent/HRP20210108T1/hr unknown
- 2018-06-25 WO PCT/IB2018/054676 patent/WO2018229738A1/en not_active Ceased
- 2018-06-25 MD MDE20200433T patent/MD3638370T2/ro unknown
- 2018-06-25 PT PT187491246T patent/PT3638370T/pt unknown
- 2018-06-25 SM SM20210037T patent/SMT202100037T1/it unknown
- 2018-06-25 AU AU2018284330A patent/AU2018284330B2/en active Active
- 2018-06-25 SG SG11201912146RA patent/SG11201912146RA/en unknown
- 2018-06-25 ES ES18749124T patent/ES2847169T3/es active Active
- 2018-06-25 SI SI201830195T patent/SI3638370T1/sl unknown
- 2018-06-25 LT LTEP18749124.6T patent/LT3638370T/lt unknown
- 2018-06-25 DK DK18749124.6T patent/DK3638370T3/da active
- 2018-06-25 RS RS20210046A patent/RS61481B1/sr unknown
- 2018-06-25 KR KR1020197038730A patent/KR102594130B1/ko active Active
- 2018-06-25 US US16/622,785 patent/US11471434B2/en active Active
-
2019
- 2019-12-05 ZA ZA2019/08087A patent/ZA201908087B/en unknown
-
2021
- 2021-01-18 CY CY20211100033T patent/CY1123860T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500016A1 (en) | Agents, uses and methods for the treatment of synucleinopathy | |
| MX387115B (es) | Métodos para tratar la influenza. | |
| ZA202409975B (en) | Methods of treating schizophrenia | |
| MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| EA201691481A1 (ru) | ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ | |
| MX2022001863A (es) | Metodos para tratar los tumores del estroma gastrointestinal. | |
| MX2025009723A (es) | Metodos de tratamiento contra adicciones | |
| WO2015126930A3 (en) | Booster drug therapy for mycobacterium infections | |
| MY194448A (en) | Short synthetic peptide for treating diseases and/or conditions related to angiogenesis | |
| PH12019550138A1 (en) | Pharmaceutical combinations for treating cancer | |
| MX381311B (es) | Método para el tratamiento de prurito y/o comezón. | |
| ZA201908087B (en) | Treatment for migraine | |
| MX2020003427A (es) | Agentes terapeuticos para enfermedades neurodegenerativas. | |
| MX373177B (es) | Métodos de tratamiento de disquinesia y trastornos relacionados. | |
| PH12020500510A1 (en) | Prophylactic and/or therapeutic agent for diseases involving ido expression | |
| EA202193276A1 (ru) | Способы лечения холангиокарциномы | |
| MY205171A (en) | Methods of treatment of hypertriglyceridemia | |
| ZA202004849B (en) | Therapeutic agents for treating restless legs syndrome | |
| MX374354B (es) | Método de curación de heridas. | |
| MY198753A (en) | Treatment of androgen deprivation therapy associated symptoms | |
| EP3881845A3 (en) | Combination of trazodone and gabapentin for the treatment of pain | |
| MX2017013453A (es) | Uso de (4-hidroxi-2-metil-1,1-dioxido-2h-benzo [e] [1, 2] tiazin-3-il) (naftalen-2-il) metanona en la prevencion y/o tratamiento de esteatohepatitis no alcoholica. | |
| PH12017501918A1 (en) | Multi-peptide composition | |
| MX2019001320A (es) | Composicion y uso de un peptido. | |
| NZ747201A (en) | (+)-azasetron for use in the treatment of ear disorders |